Cargando…

COVID-19 vaccination and cardiac dysfunction

The coronavirus disease 2019 (COVID-19) mRNA vaccine against severe acute respiratory syndrome coronavirus 2 infections has reduced the number of symptomatic patients globally. A case series of vaccine-related myocarditis or pericarditis has been published with extensive vaccination, most notably in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leowattana, Wattana, Leowattana, Tawithep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258225/ https://www.ncbi.nlm.nih.gov/pubmed/35979182 http://dx.doi.org/10.4330/wjc.v14.i6.343

Ejemplares similares

Circulating angiotensin converting enzyme 2 and COVID-19
por: Leowattana, Wattana, et al.
Publicado: (2022)

Chronic hepatitis B: New potential therapeutic drugs target
por: Leowattana, Wattana, et al.
Publicado: (2022)

Potassium-competitive acid blockers and gastroesophageal reflux disease
por: Leowattana, Wattana, et al.
Publicado: (2022)

Dengue hemorrhagic fever and the liver
por: Leowattana, Wattana, et al.
Publicado: (2021)

Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation
por: Leowattana, Wattana, et al.
Publicado: (2022)

Systemic treatment for metastatic colorectal cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Systemic treatments for resectable carcinoma of the esophagus
por: Leowattana, Wattana, et al.
Publicado: (2023)

Immunotherapy for advanced gastric cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Systemic treatment for unresectable hepatocellular carcinoma
por: Leowattana, Wattana, et al.
Publicado: (2023)

Tuberculosis of the spine
por: Leowattana, Wattana, et al.
Publicado: (2023)

Systemic treatment for advanced pancreatic cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients
por: Leowattana, Wattana
Publicado: (2021)

Nucleos(t)ide analogues treatment outcome in genotype B and C chronic hepatitis B
por: Aung, Myo Nyein, et al.
Publicado: (2010)

Increased fluidity and oxidation of malarial lipoproteins: relation with severity and induction of endothelial expression of adhesion molecules
por: Sibmooh, Nathawut, et al.
Publicado: (2004)

Risk perception of health problems among travelers visiting a travel clinic in Bangkok, Thailand
por: Hiranrusme, Thanyapat, et al.
Publicado: (2020)

Liver-spleen axis dysfunction in COVID-19
por: Cococcia, Sara, et al.
Publicado: (2021)

Mechanisms of gastrointestinal barrier dysfunction in COVID-19 patients
por: Xue, Weijie, et al.
Publicado: (2023)

COVID-19 and liver dysfunction: What nutritionists need to know
por: Wang, Ming-Ke, et al.
Publicado: (2022)

Mimicking platelet indices in patients with malaria and dengue hemorrhagic fever: characteristics and clinical applications
por: Mon, Nant The Su, et al.
Publicado: (2022)

COVID-19 vaccine-associated myocarditis
por: Morgan, Michael C, et al.
Publicado: (2022)

COVID-19 vaccination and diabetic ketoacidosis
por: Joob, Beuy, et al.
Publicado: (2023)

Implications of metabolic dysfunction associated fatty liver disease in COVID-19
por: Chakraborty, Raja, et al.
Publicado: (2023)

COVID-19 and liver dysfunction in children: Current views and new hypotheses
por: Yun, Yang-Fang, et al.
Publicado: (2023)

Heart failure in general and cardiac transplant patients with COVID-19
por: Sharma, Munish, et al.
Publicado: (2022)

Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19
por: Taneva, Gergana, et al.
Publicado: (2021)

Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy
por: Vasilev, Georgi, et al.
Publicado: (2022)

Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand
por: Thu, Aung Myint, et al.
Publicado: (2015)

Ear, nose, and throat manifestations of COVID-19 and its vaccines
por: Al-Ani, Raid M
Publicado: (2022)

COVID-19 vaccination and myocarditis: A review of current literature
por: Dhaduk, Kartik, et al.
Publicado: (2022)

Interaction between gut microbiota and COVID-19 and its vaccines
por: Leung, John S M
Publicado: (2022)

Immune-mediated liver injury following COVID-19 vaccination
por: Schinas, Georgios, et al.
Publicado: (2023)

Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity
por: Sahu, Tarun, et al.
Publicado: (2022)

COVID-19 in patients with gastrointestinal stromal tumors: Recommendations for management and vaccination
por: Snegarova, Violeta, et al.
Publicado: (2022)

COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
por: Moore, John P., et al.
Publicado: (2020)

Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art
por: Ivanov, Nedelcho, et al.
Publicado: (2023)

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
por: McLean, Gary, et al.
Publicado: (2022)

Role of cardiac magnetic resonance imaging in the diagnosis and management of COVID-19 related myocarditis: Clinical and imaging considerations
por: Atri, Lavannya, et al.
Publicado: (2021)

Hemostasis testing in patients with liver dysfunction: Advantages and caveats
por: Nguyen, Guillaume, et al.
Publicado: (2021)

Role of immune dysfunction in drug induced liver injury
por: Girish, Chandrashekaran, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q4r8m557q8m4a9vsa12bebutep